Search for Possible Associations of FTO Gene Polymorphic Variants with Metabolic Syndrome, Obesity and Body Mass Index in Schizophrenia Patients

Anastasiia S Boiko,1,* Ivan V Pozhidaev,1,* Diana Z Paderina,1 Anna V Bocharova,2 Irina A Mednova,1 Olga Yu Fedorenko,1 Elena G Kornetova,3,4 Anton JM Loonen,5 Arkadiy V Semke,3 Nikolay A Bokhan,6,7 Svetlana A Ivanova1,7 1Molecular Genetics and Biochemistry Laboratory, Mental Health...

Full description

Bibliographic Details
Main Authors: Boiko AS, Pozhidaev IV, Paderina DZ, Bocharova AV, Mednova IA, Fedorenko OY, Kornetova EG, Loonen AJM, Semke AV, Bokhan NA, Ivanova SA
Format: Article
Language:English
Published: Dove Medical Press 2021-09-01
Series:Pharmacogenomics and Personalized Medicine
Subjects:
Online Access:https://www.dovepress.com/search-for-possible-associations-of-fto-gene-polymorphic-variants-with-peer-reviewed-fulltext-article-PGPM
_version_ 1818601859686858752
author Boiko AS
Pozhidaev IV
Paderina DZ
Bocharova AV
Mednova IA
Fedorenko OY
Kornetova EG
Loonen AJM
Semke AV
Bokhan NA
Ivanova SA
author_facet Boiko AS
Pozhidaev IV
Paderina DZ
Bocharova AV
Mednova IA
Fedorenko OY
Kornetova EG
Loonen AJM
Semke AV
Bokhan NA
Ivanova SA
author_sort Boiko AS
collection DOAJ
description Anastasiia S Boiko,1,* Ivan V Pozhidaev,1,* Diana Z Paderina,1 Anna V Bocharova,2 Irina A Mednova,1 Olga Yu Fedorenko,1 Elena G Kornetova,3,4 Anton JM Loonen,5 Arkadiy V Semke,3 Nikolay A Bokhan,6,7 Svetlana A Ivanova1,7 1Molecular Genetics and Biochemistry Laboratory, Mental Health Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk, Russian Federation; 2Laboratory of Evolutionary Genetics, Research Institute of Medical Genetics, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk, Russian Federation; 3Endogenous Disorders Department, Mental Health Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk, Russian Federation; 4University Hospital, Siberian State Medical University, Tomsk, Russian Federation; 5Unit of Pharmacotherapy, Epidemiology & Economics, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, the Netherlands; 6Addictive Disorders Department, Mental Health Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk, Russian Federation; 7Psychiatry, Addiction Psychiatry and Psychotherapy Department, Siberian State Medical University, Tomsk, Russian Federation*These authors contributed equally to this workCorrespondence: Anton JM LoonenUnit of Pharmacotherapy, Epidemiology & Economics, Groningen Research Institute of Pharmacy, University of Groningen, Antonius Deusinglaan 1, Groningen, 9713AV, the NetherlandsTel +31 50 363 7576Email a.j.m.loonen@rug.nlPurpose: Metabolic syndrome (MetS) is characterized by abdominal obesity, hyperglycaemia, dyslipidaemia and hypertension. FTO gene has been implicated in the pathogenesis of obesity, but the available scientific data concerning their relationship to antipsychotic drug-induced obesity and metabolic syndrome is still incomplete and inconsistent, which indicates that continuing the investigation of this gene’s role is necessary.Patients and Methods: In the present study, 517 patients with schizophrenia underwent antipsychotic drug treatment, and two groups were identified: patients with MetS and without MetS. Genotyping of 6 SNPs in the FTO gene was performed, and the results analyzed using R-programme.Results: We performed a statistical analysis to identify possible associations of the frequencies of genotypes and alleles of the studied polymorphisms with the presence of metabolic syndrome in schizophrenia patients, with the presence of abdominal obesity, and with an increased body mass index. The rs7185735 polymorphism did not meet the Hardy-Weinberg criterion and was excluded. After correcting for differences in age, gender and duration of illnesses, none of the variants was shown to be related to metabolic syndrome or abdominal obesity, but rs9939609, rs1421085, rs3751812 and rs8050136 were associated with body mass index.Conclusion: The present study provides additional support for these SNP’s roles as a pharmacogenetic biomarker that may become useful in the framework of the personalized medicine approach.Keywords: schizophrenia, gene polymorphism, body weight, waist circumference, fat mass and obesity associated gene
first_indexed 2024-12-16T12:58:05Z
format Article
id doaj.art-681ff755b9ad4ad0a2daade7eb21631a
institution Directory Open Access Journal
issn 1178-7066
language English
last_indexed 2024-12-16T12:58:05Z
publishDate 2021-09-01
publisher Dove Medical Press
record_format Article
series Pharmacogenomics and Personalized Medicine
spelling doaj.art-681ff755b9ad4ad0a2daade7eb21631a2022-12-21T22:30:57ZengDove Medical PressPharmacogenomics and Personalized Medicine1178-70662021-09-01Volume 141123113168630Search for Possible Associations of FTO Gene Polymorphic Variants with Metabolic Syndrome, Obesity and Body Mass Index in Schizophrenia PatientsBoiko ASPozhidaev IVPaderina DZBocharova AVMednova IAFedorenko OYKornetova EGLoonen AJMSemke AVBokhan NAIvanova SAAnastasiia S Boiko,1,* Ivan V Pozhidaev,1,* Diana Z Paderina,1 Anna V Bocharova,2 Irina A Mednova,1 Olga Yu Fedorenko,1 Elena G Kornetova,3,4 Anton JM Loonen,5 Arkadiy V Semke,3 Nikolay A Bokhan,6,7 Svetlana A Ivanova1,7 1Molecular Genetics and Biochemistry Laboratory, Mental Health Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk, Russian Federation; 2Laboratory of Evolutionary Genetics, Research Institute of Medical Genetics, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk, Russian Federation; 3Endogenous Disorders Department, Mental Health Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk, Russian Federation; 4University Hospital, Siberian State Medical University, Tomsk, Russian Federation; 5Unit of Pharmacotherapy, Epidemiology & Economics, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, the Netherlands; 6Addictive Disorders Department, Mental Health Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk, Russian Federation; 7Psychiatry, Addiction Psychiatry and Psychotherapy Department, Siberian State Medical University, Tomsk, Russian Federation*These authors contributed equally to this workCorrespondence: Anton JM LoonenUnit of Pharmacotherapy, Epidemiology & Economics, Groningen Research Institute of Pharmacy, University of Groningen, Antonius Deusinglaan 1, Groningen, 9713AV, the NetherlandsTel +31 50 363 7576Email a.j.m.loonen@rug.nlPurpose: Metabolic syndrome (MetS) is characterized by abdominal obesity, hyperglycaemia, dyslipidaemia and hypertension. FTO gene has been implicated in the pathogenesis of obesity, but the available scientific data concerning their relationship to antipsychotic drug-induced obesity and metabolic syndrome is still incomplete and inconsistent, which indicates that continuing the investigation of this gene’s role is necessary.Patients and Methods: In the present study, 517 patients with schizophrenia underwent antipsychotic drug treatment, and two groups were identified: patients with MetS and without MetS. Genotyping of 6 SNPs in the FTO gene was performed, and the results analyzed using R-programme.Results: We performed a statistical analysis to identify possible associations of the frequencies of genotypes and alleles of the studied polymorphisms with the presence of metabolic syndrome in schizophrenia patients, with the presence of abdominal obesity, and with an increased body mass index. The rs7185735 polymorphism did not meet the Hardy-Weinberg criterion and was excluded. After correcting for differences in age, gender and duration of illnesses, none of the variants was shown to be related to metabolic syndrome or abdominal obesity, but rs9939609, rs1421085, rs3751812 and rs8050136 were associated with body mass index.Conclusion: The present study provides additional support for these SNP’s roles as a pharmacogenetic biomarker that may become useful in the framework of the personalized medicine approach.Keywords: schizophrenia, gene polymorphism, body weight, waist circumference, fat mass and obesity associated genehttps://www.dovepress.com/search-for-possible-associations-of-fto-gene-polymorphic-variants-with-peer-reviewed-fulltext-article-PGPMschizophreniagene polymorphismbody weightwaist circumferencefat mass and obesity associated gene
spellingShingle Boiko AS
Pozhidaev IV
Paderina DZ
Bocharova AV
Mednova IA
Fedorenko OY
Kornetova EG
Loonen AJM
Semke AV
Bokhan NA
Ivanova SA
Search for Possible Associations of FTO Gene Polymorphic Variants with Metabolic Syndrome, Obesity and Body Mass Index in Schizophrenia Patients
Pharmacogenomics and Personalized Medicine
schizophrenia
gene polymorphism
body weight
waist circumference
fat mass and obesity associated gene
title Search for Possible Associations of FTO Gene Polymorphic Variants with Metabolic Syndrome, Obesity and Body Mass Index in Schizophrenia Patients
title_full Search for Possible Associations of FTO Gene Polymorphic Variants with Metabolic Syndrome, Obesity and Body Mass Index in Schizophrenia Patients
title_fullStr Search for Possible Associations of FTO Gene Polymorphic Variants with Metabolic Syndrome, Obesity and Body Mass Index in Schizophrenia Patients
title_full_unstemmed Search for Possible Associations of FTO Gene Polymorphic Variants with Metabolic Syndrome, Obesity and Body Mass Index in Schizophrenia Patients
title_short Search for Possible Associations of FTO Gene Polymorphic Variants with Metabolic Syndrome, Obesity and Body Mass Index in Schizophrenia Patients
title_sort search for possible associations of fto gene polymorphic variants with metabolic syndrome obesity and body mass index in schizophrenia patients
topic schizophrenia
gene polymorphism
body weight
waist circumference
fat mass and obesity associated gene
url https://www.dovepress.com/search-for-possible-associations-of-fto-gene-polymorphic-variants-with-peer-reviewed-fulltext-article-PGPM
work_keys_str_mv AT boikoas searchforpossibleassociationsofftogenepolymorphicvariantswithmetabolicsyndromeobesityandbodymassindexinschizophreniapatients
AT pozhidaeviv searchforpossibleassociationsofftogenepolymorphicvariantswithmetabolicsyndromeobesityandbodymassindexinschizophreniapatients
AT paderinadz searchforpossibleassociationsofftogenepolymorphicvariantswithmetabolicsyndromeobesityandbodymassindexinschizophreniapatients
AT bocharovaav searchforpossibleassociationsofftogenepolymorphicvariantswithmetabolicsyndromeobesityandbodymassindexinschizophreniapatients
AT mednovaia searchforpossibleassociationsofftogenepolymorphicvariantswithmetabolicsyndromeobesityandbodymassindexinschizophreniapatients
AT fedorenkooy searchforpossibleassociationsofftogenepolymorphicvariantswithmetabolicsyndromeobesityandbodymassindexinschizophreniapatients
AT kornetovaeg searchforpossibleassociationsofftogenepolymorphicvariantswithmetabolicsyndromeobesityandbodymassindexinschizophreniapatients
AT loonenajm searchforpossibleassociationsofftogenepolymorphicvariantswithmetabolicsyndromeobesityandbodymassindexinschizophreniapatients
AT semkeav searchforpossibleassociationsofftogenepolymorphicvariantswithmetabolicsyndromeobesityandbodymassindexinschizophreniapatients
AT bokhanna searchforpossibleassociationsofftogenepolymorphicvariantswithmetabolicsyndromeobesityandbodymassindexinschizophreniapatients
AT ivanovasa searchforpossibleassociationsofftogenepolymorphicvariantswithmetabolicsyndromeobesityandbodymassindexinschizophreniapatients